鲍曼不动杆菌耐药率与抗菌药物用量的相关性分析

吴建均; 鲍颖菲; 赵扬; 蔡和平; 杨樟卫; 周佳; 王学彬; 陈翠敏

doi:10.3969/j.issn.1006-0111.2015.05.024

鲍曼不动杆菌耐药率与抗菌药物用量的相关性分析

doi: 10.3969/j.issn.1006-0111.2015.05.024

1.
西藏军区总医院药剂科, 西藏拉萨 850007
2.
第二军医大学附属长海医院药学部, 上海 200433
3.
国家食品药品监督管理局高级研修学院, 北京 100073

基金项目: 第二军医大学长海医院"1255"课题——学科特色提升项目(CH125520400)

The correlation between the resistance rate of Acinetobacter baumannii and antimicrobial consumption

1.
Department of Pharmacy, General Hospital of Tibet Military Region, Lhasa 850007, China
2.
Department of Pharmacy, Changhai Hospital Affialated to Second Military Medical University, Shanghai 200433, China
3.
State Food and Drug Administration Institute of Executive Development, Beijing 100073, China

摘要: 目的通过对某三级医院2007-2010年抗菌药物的使用情况与鲍曼不动杆菌对各类抗菌药物的耐药性进行相关性分析,探讨鲍曼不动杆菌耐药性变化与抗菌药物用量的相关性,为临床合理用药提供依据。方法回顾性调查某三级医院2007-2010年常用抗菌药物的用药量与用药频度(DDDs),同时统计同期鲍曼不动杆菌对相关抗菌药物的耐药率,应用SAS 8.2 统计软件包进行数据分析,用Spearman相关法进行相关性分析。结果鲍曼不动杆菌对亚胺培南的耐药率与碳青霉烯类药物的用量呈显著正相关(r=0.954 6,P<0.01),与亚胺培南用量呈正相关(r=0.849 2,P<0.05);鲍曼不动杆菌对美罗培南的耐药率与其用量呈正相关(r=0.999 2,P<0.05),对阿莫西林-克拉维酸钾的耐药率与其用量呈正相关(r=0.800 5,P<0.05);鲍曼不动杆菌对氨基糖苷类药物、氟喹诺酮类、β-内酰胺酶抑制剂的耐药率与上述药物的用量未见统计学相关(P>0.05)。结论对碳青霉烯类药物的使用应严格掌握适应证,用于鲍曼不动杆菌所致感染时应仅限于重症患者;氨基糖苷类药物阿米卡星与β-内酰胺酶抑制剂头孢哌酮-舒巴坦是治疗鲍曼不动杆菌感染较好的选择。
- 鲍曼不动杆菌 /
- 耐药性 /
- 抗菌药物用量 /
- 相关性
Abstract: Objective To analyze the relevance between the consumption of various antimicrobials and antimicrobial resistance of Acinetobacter baumanni in a grade three hospital during 2007-2010. Methods A retrospective analysis was performed to count and sort the defined daily doses (DDDs) and the consumption of various antimicrobials in the hospital between 2007 and 2010. Meanwhile the resistance rates of Acinetobacter baumanni to different antimicrobials were collected in the same period. Data was analyzed by SAS 8.2 statistical software package using Spearman correlation method. Results The resistance rate of Acinetobacter baumanni to imipenem was significantly positively correlated with the consumption of carbapenems (r=0.954 6, P<0.01), it is positively correlated with the dosage of imipenem (r=0.849 2,P<0.05), it is also significantly positively correlated with the consumption of meropenem (r=0.999 2,P<0.05),and the consumption of amoxicillin/clavulanate potassium, respectively(r=0.800 5,P<0.05). There was no correlation between the resistance rate of Acinetobacter baumanni and the dosage of aminoglycosides, fluoroquinolones, even β-lactamase inhibitors(P>0.05). Conclusion The use of carbapenems should be correlated with their indications strictly, only applying to severe infection of Acinetobacter baumanni. The aminoglycosides of amikacin and β-lactamase inhibitors of cefoperazone/sulbactam are the better options to treat Acinetobacter baumanni infection.
- Acinetobacter baumannii /
- drug resistance /
- consumption of antibacterial agents /
- correlation

[1]	Jiang M, Zhang Z, Zhao S. Epidemiological characteristics and drug resistance analysis of multidrug-resistant Acinetobacter baumannii in a China hospital at a certain time[J]. Pol J Microbiol, 2014,63(3):275-281.
[2]	Muraki Y,Kitamura M,Maeda Y,et al.Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010 [J].Infection,2013,41(2):415-423.
[3]	马序竹,吕媛.鲍曼不动杆菌对主要抗菌药物耐药机制[J].中国临床药理学杂志,2009,25(1):90-94.
[4]	应舂妹,翁文浩.鲍曼不动杆菌多重耐药机制研究进展[J].检验医学,2007,22(2):208-212.
[5]	王艳丽,黄茂,梅亚宁,等.鲍曼不动杆菌对喹诺酮类药物的耐药机制研究[J].中国感染与化疗杂志,2008,8(4):266-270.
[6]	Bergogne BE,Joly-Guillou ML,Towner KJ.Acinetobacter microbiology,epidemiology,infections,management [M].New York:CRC Press,1996:101-115.
[7]	Bou G,Cervero G,Dominguez MA,et al.Characterization of a nosocomial outbreak caused by a multiresisrant Acinetobacter baumannii strain with a carbapenemhydrolyzing enzyme:high-level carbapenem resistance in A.baumannii is not due solely to the presence of β-lactamases[J].J Clin Microbiol,2000,38:3299-3305.

[1]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[2]	杨嘉宁, 赵一颖, 肖伟. 七味脂肝方对非酒精性脂肪性肝炎动物模型的药效学评价 . 药学实践与服务, 2024, 42(9): 389-398. doi: 10.12206/j.issn.2097-2024.202404096
[3]	迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛. 负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
[4]	夏哲炜, 曾垣烨, 朱海菲, 李育, 陈啸飞. 核磁共振磷谱法测定磷酸氢钙咀嚼片中药物含量 . 药学实践与服务, 2024, 42(9): 399-401, 406. doi: 10.12206/j.issn.2097-2024.202404063
[5]	戴菲菲, 傅翔, 陈琼年, 俞苏纯. 上海某二级医院革兰阴性菌流行特征的回顾性分析 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202305005
[6]	王耀振, 徐灿, 吕顺莉, 田泾, 张东炜. 钾离子竞争性酸阻滞剂的药学特征研究进展 . 药学实践与服务, 2024, 42(7): 278-284. doi: 10.12206/j.issn.2097-2024.202306040
[7]	张晶晶, 索丽娜, 郑兆红. 89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
[8]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[9]	张岩, 李炎君, 刘家荟, 邓娇, 原苑, 张敬一. 药物性肝损伤不良反应分析 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404034
[10]	张元林, 宋凯, 孙蕊, 舒飞, 舒丽芯, 杨樟卫. 基于真实世界数据的药物利用研究综述 . 药学实践与服务, 2024, 42(6): 238-243. doi: 10.12206/j.issn.2097-2024.202312010
[11]	史生辉, 石飞, 雷琼, 王亚峰, 吴雪花. 青藏高原肺结核合并念珠菌感染患者的病原菌分布特点及耐药率分析 . 药学实践与服务, 2024, 42(6): 260-262, 272. doi: 10.12206/j.issn.2097-2024.202304014
[12]	姚小静, 计佩影, 陆峰, 施国荣, 傅翔. 表面增强拉曼光谱法快速测定尿液中曲马多的研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202401072
[13]	张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英. 二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
[14]	钱淑雨, 李铁军. 耐碳青霉烯类肠杆菌耐药机制的研究进展 . 药学实践与服务, 2024, 42(10): 419-425. doi: 10.12206/j.issn.2097-2024.202405005
[15]	桂明珠, 李静, 李志玲. 儿童伏立康唑的血药浓度与CYP2C19、CYP2C9和CYP3A5基因多态性的相关性研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402020
[16]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[17]	陈怡君, 王卓, 何苗, 张宇, 田泾. 泌尿系统碎石术抗菌药物预防使用合理管控实践 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402034
[18]	唐淑慧, 凤美娟, 薛智霞, 鲁桂华. 帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
[19]	黄韵, 张正银, 金英, 郑怡菁, 李铁军, 孙莉莉. 耐碳青霉烯类肺炎克雷伯菌及大肠埃希菌临床分离株耐药性及耐药基因分析 . 药学实践与服务, 2024, 42(10): 439-444. doi: 10.12206/j.issn.2097-2024.202309059

点击查看大图

计量

文章访问数: 3012
HTML全文浏览量: 256
PDF下载量: 552
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

鲍曼不动杆菌耐药率与抗菌药物用量的相关性分析

doi: 10.3969/j.issn.1006-0111.2015.05.024

The correlation between the resistance rate of Acinetobacter baumannii and antimicrobial consumption

计量

鲍曼不动杆菌耐药率与抗菌药物用量的相关性分析

doi: 10.3969/j.issn.1006-0111.2015.05.024

1. 西藏军区总医院药剂科, 西藏拉萨 850007

2. 第二军医大学附属长海医院药学部, 上海 200433

3. 国家食品药品监督管理局高级研修学院, 北京 100073

English Abstract

The correlation between the resistance rate of Acinetobacter baumannii and antimicrobial consumption

全文HTML

目录

留言板

鲍曼不动杆菌耐药率与抗菌药物用量的相关性分析

doi: 10.3969/j.issn.1006-0111.2015.05.024

The correlation between the resistance rate of Acinetobacter baumannii and antimicrobial consumption

计量

出版历程

鲍曼不动杆菌耐药率与抗菌药物用量的相关性分析

doi: 10.3969/j.issn.1006-0111.2015.05.024

1. 西藏军区总医院药剂科, 西藏 拉萨 850007 2. 第二军医大学附属长海医院药学部, 上海 200433 3. 国家食品药品监督管理局高级研修学院, 北京 100073

English Abstract

The correlation between the resistance rate of Acinetobacter baumannii and antimicrobial consumption

全文HTML

目录

1. 西藏军区总医院药剂科, 西藏拉萨 850007

2. 第二军医大学附属长海医院药学部, 上海 200433

3. 国家食品药品监督管理局高级研修学院, 北京 100073